Home › Funds › Keebeck Wealth Management › ABBV

Keebeck Wealth Management position in ABBV

ABBVIE INC · Health Care

Keebeck Wealth Management reported holding 21,839 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$5.7M, representing 0.56% of its reported portfolio and ranking #41 among its reported holdings. Keebeck Wealth Management has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)21.84K sh
Reported value held$5.71M
Portfolio Weight0.56%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Keebeck Wealth Management's ABBV position evolved

Keebeck Wealth Management first disclosed a stake in ABBV in Q3 2023 at 3,215 shares (US$479K). The position peaked in Q3 2026 at 21,839 shares, worth US$5.7M. Across 13 filings, Keebeck Wealth Management increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 21,839 shares valued at US$5.7M — a reduction of -166 shares quarter over quarter.. Notable position changes include a 406% increase in Q1 2024 (shares fell 5% over the following quarter), a 52% increase in Q2 2024 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.21K $479.24K New
Q4 2023 3.29K $510.20K Add
Q1 2024 16.67K $3.04M Add
Q2 2024 25.38K $4.35M Add
Q3 2024 25.15K $4.97M Reduce
Q4 2024 25.01K $4.44M Reduce
Q1 2025 25.16K $5.27M Add
Q2 2025 24.61K $4.57M Reduce
Q3 2025 24.55K $5.68M Hold
Q4 2025 23.93K $5.47M Reduce
Q1 2026 20.60K $4.48M Reduce
Q2 2026 22.00K $5.54M Add
Q3 2026 21.84K $5.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Keebeck Wealth Management held ABBV?

Keebeck Wealth Management has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Keebeck Wealth Management's current position in ABBV?

As of Q3 2026, Keebeck Wealth Management holds 21.84K shares of ABBV (ABBVIE INC), valued at $5.71M, representing 0.56% of its reported portfolio and ranking #41.

Has Keebeck Wealth Management been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Keebeck Wealth Management reduced its position in ABBV. The position peaked in Q3 2026 at 21.84K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.